BTZ-043 Dose Evaluation in Combination and Selection
Conditions: Tuberculosis, Pulmonary; Other Specified Pulmonary Tuberculosis Interventions: Drug: BTZ-043; Drug: Bedaquiline; Drug: Delamanid; Drug: Moxifloxacin Sponsors: Michael Hoelscher; Radboud University Medical Center; University of California, San Francisco; University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials